Last reviewed · How we verify

Local instillation of Levofloxacin and Budesonide

Assiut University · FDA-approved active Small molecule Quality 2/100

Local instillation of Levofloxacin and Budesonide is a Small molecule drug developed by Assiut University. It is currently FDA-approved. Also known as: Bronchoscopic instillation of levofloxacin and steroids.

At a glance

Generic nameLocal instillation of Levofloxacin and Budesonide
Also known asBronchoscopic instillation of levofloxacin and steroids
SponsorAssiut University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Local instillation of Levofloxacin and Budesonide

What is Local instillation of Levofloxacin and Budesonide?

Local instillation of Levofloxacin and Budesonide is a Small molecule drug developed by Assiut University.

Who makes Local instillation of Levofloxacin and Budesonide?

Local instillation of Levofloxacin and Budesonide is developed and marketed by Assiut University (see full Assiut University pipeline at /company/assiut-university).

Is Local instillation of Levofloxacin and Budesonide also known as anything else?

Local instillation of Levofloxacin and Budesonide is also known as Bronchoscopic instillation of levofloxacin and steroids.

What development phase is Local instillation of Levofloxacin and Budesonide in?

Local instillation of Levofloxacin and Budesonide is FDA-approved (marketed).

Related